findmyKOL

Thorsten Leucker, MD

Enriched profile

Associate Professor of Medicine; Director, Johns Hopkins Cardiovascular Clinical Research Unit (JH-CCRU); Director, Cardiology (Cardiovascular Disease) Fellowship Program; Director of Basic and Translational Vascular Biology Research, Ciccarone Center for the Prevention of Cardiovascular Disease · Johns Hopkins University School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Baltimore, MD · Northeast · United StatesSpecialtyCardiovascular DiseaseFocusLipoproteins and Cardiovascular Health+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2024–2026

Thorsten Leucker is Associate Professor of Medicine; Director, Johns Hopkins Cardiovascular Clinical Research Unit (JH-CCRU); Director, Cardiology (Cardiovascular Disease) Fellowship Program; Director of Basic and Translational Vascular Biology Research, Ciccarone Center for the Prevention of Cardiovascular Disease at Johns Hopkins University School of Medicine. OpenAlex indexes 129 publications with 2,670 citations (h-index 28); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.

Data verified 16 Oct 2026

Overview

Updated 16 Oct 2026

Thorsten Leucker, M.D., is Associate Professor of Medicine at Johns Hopkins University School of Medicine, Division of Cardiology, Baltimore, MD. The public record shows 129 publications with 2,670 citations (h-index 28), centered on Lipoproteins and Cardiovascular Health, Atherosclerosis and Cardiovascular Diseases, Cardiac Imaging and Diagnostics. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 6 companies, 1 NIH-funded awards (2024–2026).

  • Most recent indexed publication: 2026 · American journal of physiology. Heart and circulatory physiology
  • Top research focus: Lipoproteins and Cardiovascular Health
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 6 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Coronary Artery Disease / ACS2 trialsAcute Coronary Syndrome2 trialsMetabolic Syndrome1 trialType 2 DiabetesDyslipidemia / Lipid DisordersHIV

Research focus

OpenAlex concept fingerprint
Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular DiseasesCardiac Imaging and DiagnosticsHIV-related health complications and treatmentsDiabetes, Cardiovascular Risks, and Lipoproteins

Drugs & molecules

across trials, industry payments and publications
Repathageneric · EvolocumabClinical trials—Industry payments3Publications2Rybelsusgeneric · SemaglutideClinical trials—Industry payments8Publications—Leqviogeneric · InclisiranClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Novo Nordisk IncClinical trials—Industry payments6Amgen Inc.Clinical trials—Industry payments5Johns Hopkins UniversityClinical trials3Industry payments—Novartis Pharmaceuticals CorporationClinical trials—Industry payments3Novartis PharmaceuticalsClinical trials2Industry payments—AbiomedClinical trials—Industry payments1Merck Sharp & Dohme CorporationClinical trials—Industry payments1Merck Sharp & Dohme LLCClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
129publications

Distinct works indexed by OpenAlex, matched via ORCID; 17 in PubMed.

2,670citations

Total citations across indexed works.

28h-index

Hirsch index (OpenAlex). i10-index 40.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
6companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2024–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    96.8%
    PCSK9 Inhibitor63%
    Repatha Sureclick78%Praluent Pen23%
    Part D≥43 patients
    Cholesterol absorption inhibitor15.9%
    Ezetimibe100%
    Part D≥18 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    3.2%
    GLP-1 receptor agonist3.2%
    Ozempic100%
    Part D<11 patients
Where care is delivered (Part B)97.7% facility · 2.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Gary Gerstenblith50Tarek Harb30Steven R. Jones27Efthymios Ziogos24Allison G. Hays15Thomas H. Schindler14Michael J. Blaha12Seth S. Martin12Michael Vavuranakis10Michael Schär10Roger S. Blumenthal10Steven P. Schulman8Robert G. Weiss8Marlene S. Williams7Anum Minhas7Todd T. Brown7Lakshmi Santhanam6Nadim Nasrallah6Nuria Amat-Codina6David C. Warltier6Judy R. Kersten6Marios Arvanitis5Ines Valenta5Zhi‐Dong Ge5Erin D. Michos5Peter P. Tóth5Kathleen Byrne5Jacqueline Latina4Stephen P. Chelko4David J. Polhemus4Shenghan Lai4Martha Gulati4Emily Brown4Shenghan Lai4Nikolaos G. Frangogiannis4Rhanderson Cardoso4Diego Almodiel4Deepesh Pandey4Yohei Nomura4Manolis Vavuranakis3

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/thorsten-leucker-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/thorsten-leucker-a0823b178

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/profile/Thorsten-Leucker

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/TLeucker

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Other

    medicine-matters.blogs.hopkinsmedicine.org/2022/10/leucker-named-director-of-cardiovascular-diseases-fellowship-program

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine-matters.blogs.hopkinsmedicine.org ↗
  • Other

    medicine-matters.blogs.hopkinsmedicine.org/2025/04/leucker-post-and-segal-receive-dom-mentoring-awards

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine-matters.blogs.hopkinsmedicine.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    Cardiovascular Disease, American Board of Internal Medicine

    2017
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Ph.D.

    University of Bonn (Rheinische Friedrich-Wilhelms-Universität Bonn), 2011, summa cum laude

    2011
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.hopkinsmedicine.org ↗
  • M.D.

    University of Bonn Faculty of Medicine (Rheinische Friedrich-Wilhelms-Universität Bonn), 2008, summa cum laude

    2008
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Diplomate

    American Board of Clinical Lipidology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.hopkinsmedicine.org ↗

Awards & honors

honors on the public record
  • Recipient

    AHA Clinical Fellow Research Education Program funding for the Johns Hopkins Cardiology Fellowship Program

    2023
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine-matters.blogs.hopkinsmedicine.org ↗
  • 1st Place

    Northwestern Cardiovascular Young Investigator's Forum

    2018
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Howard S. Silverman Award

    Johns Hopkins Division of Cardiology

    2016
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Fellow

    American Heart Association

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • Fellow

    American College of Cardiology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.